PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15788899-9	2005	Both PNAs and TFOs were effective at binding the target sequence in naked genomic DNA, but only the TFO-alkylator (TFO2) and the more cationic PNA (PNA2) were detected at the endogenous HER-2/neu promoter in permeabilized cells.	tfo	14-17	erb-b2 receptor tyrosine kinase 2	Homo sapiens	186-195	
15788899-8	2005	The cpy-bis-PNAs and the TFO-alkylator conjugate prevented HER-2/neu transcription in a reporter gene assay (TFO2 = PNA1 > PNA2 >> TFO1).	tfo	25-28	erb-b2 receptor tyrosine kinase 2	Homo sapiens	59-68	
15546183-2	2004	To stabilize binding to a polypurine tract in the HER-2/neu promoter, a triplex forming oligonucleotide (TFO) was conjugated to a pyrrolo[1,4]benzodiazepine (PBD), desmethyltomaymycin, and site-specific DNA binding was evaluated.	tfo	105-108	erb-b2 receptor tyrosine kinase 2	Homo sapiens	50-59	
11691913-3	2001	This study uses a TFO-chlorambucil (chl) conjugate capable of forming site-specific covalent guanine adducts within the HER-2/neu promoter.	tfo	18-21	erb-b2 receptor tyrosine kinase 2	Homo sapiens	120-129	
34740907-1	2022	Triplex-forming oligonucleotides (TFO) were used to directly target amplified HER2 loci in breast tumors.	tfo	34-37	erb-b2 receptor tyrosine kinase 2	Homo sapiens	78-82